Atox Bio Announces Oral Presentation At The 35th Annual Meeting Of The Surgical Infection Society

NESS ZIONA, Israel--(BUSINESS WIRE)--Atox Bio, developer of therapeutics for severe infections, today announced that an oral presentation titled “Impact and Progression of Organ Dysfunction in Patients with Necrotizing Soft Tissue Infections; A multicenter study” will be presented by Dr. Eileen Bulger, Chief of Trauma for Harborview Medical Center, at the 35th annual meeting of the Surgical Infection Society.

Help employers find you! Check out all the jobs and post your resume.